Guangzhou Baiyunshan Pharmaceutical Holdings Company (HK:0874) has released an update.
Guangzhou Baiyunshan Pharmaceutical Holdings Company is set to amend its Articles of Association to reflect recent regulatory changes in China and updates to the Hong Kong Listing Rules. The proposed amendments, which do not alter class meeting requirements, aim to update provisions related to corporate communication practices, management of independent directors, and the company’s dividend policy. Shareholders will vote on these amendments, viewed as aligning with the company’s interests, at a general meeting scheduled on or before September 30, 2024.
For further insights into HK:0874 stock, check out TipRanks’ Stock Analysis page.
